Icon partners with KoNECT to advance S. Korean clinical trials industry

Wednesday, October 3, 2012 10:43 AM

Icon, a global provider of outsourced development services, and Korea National Enterprise for Clinical Trials (KoNECT) have signed a partnership agreement that aims to advance the clinical trials industry in South Korea.

Icon and KoNECT will collaborate on a series of educational events for local and multinational pharmaceutical companies, investigators and industry officials. The programs aim to further enhance the already high standards of clinical research in South Korea and will kick off with an oncology trials seminar in Seoul on October 26.

“South Korea has become a key country for clinical development and Icon has had a well-established presence there since 2005,” said Wei Ming Goh, vice president, Asia-Pacific, Icon. “Our agreement with KoNECT supports our mutual interest in developing and growing the clinical research industry in South Korea and demonstrates our on-going commitment to the Asia Pacific region.” 

KoNECT president, Sang-Goo Shin, added, “We are delighted to collaborate with a leading clinical research organisation such as Icon that has a wealth of expertise in both local and global clinical development programs. Together we can develop high quality clinical research professionals and a clinical trials infrastructure that can support the increased demand from local and global pharma companies.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs